Literature DB >> 18068870

Pregnenolone sulfate in the brain: a controversial neurosteroid.

Michael Schumacher1, Philippe Liere, Yvette Akwa, Krzysztof Rajkowski, William Griffiths, Karl Bodin, Jan Sjövall, Etienne-Emile Baulieu.   

Abstract

Pregnenolone sulfate (PREGS) has been shown, either at high nanomolar or at micromolar concentrations, to increase neuronal activity by inhibiting GABAergic and by stimulating glutamatergic neurotransmission. PREGS is also a potent modulator of sigma type 1 (sigma1) receptors. It has been proposed that these actions of PREGS underlie its neuropharmacological effects, and in particular its influence on memory processes. On the other hand, the PREGS-mediated increase in neuronal excitability may become dangerous under particular conditions, for example in the case of excitotoxic stress or convulsions. However, the physiopathological significance of these observations has recently been put into question by the failure to detect significant levels of PREGS within the brain and plasma of rats and mice, either by direct analytical methods based on liquid chromatography/mass spectrometry (LC/MS) or enzyme linked immunosorbent assay (ELISA) with specific antibodies against PREGS, or by indirect gas chromatography/mass spectrometry (GC/MS) analysis with improved sample workup. These recent results have not come to the attention of a large number of neurobiologists interested in steroid sulfates. However, although available direct analytical methods have failed to detect levels of PREGS above 0.1-0.3 ng/g in brain tissue, it may be premature to completely exclude the local formation of biologically active PREGS within specific and limited compartments of the nervous system. In contrast to the situation in rodents, significant levels of sulfated 3beta-hydroxysteroids have been measured in human plasma and brain. Previous indirect measures of steroid sulfates by radioimmunoassays (RIA) or GC/MS had detected elevated levels of PREGS in rodent brain. The discrepancies between the results of different assay procedures have revealed the danger of indirect analysis of steroid sulfates. Indeed, PREGS must be solvolyzed/hydrolyzed prior to RIA or GC/MS analysis, and it is the released, unconjugated PREG which is then quantified. Extreme caution needs to be exercised during the preparation of samples for RIA or GC/MS analysis, because the fraction presumed to contain only steroid sulfates can be contaminated by nonpolar components from which PREG is generated by the solvolysis/hydrolysis/derivatization reactions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18068870     DOI: 10.1016/j.neuint.2007.08.022

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  35 in total

1.  Complex actions of estradiol-3-sulfate in late gestation fetal brain.

Authors:  Jared Winikor; Christine Schlaerth; Maria Belen Rabaglino; Roderick Cousins; Monique Sutherland; Charles E Wood
Journal:  Reprod Sci       Date:  2011-01-27       Impact factor: 3.060

2.  Activation of steroid-sensitive TRPM3 channels potentiates glutamatergic transmission at cerebellar Purkinje neurons from developing rats.

Authors:  Paula A Zamudio-Bulcock; Julie Everett; Christian Harteneck; C Fernando Valenzuela
Journal:  J Neurochem       Date:  2011-09-28       Impact factor: 5.372

3.  Neurosteroid transport by the organic solute transporter OSTα-OSTβ.

Authors:  Fang Fang; Whitney V Christian; Sadie G Gorman; Mei Cui; Jiaoti Huang; Kim Tieu; Nazzareno Ballatori
Journal:  J Neurochem       Date:  2010-08-12       Impact factor: 5.372

4.  A steroid modulatory domain in NR2A collaborates with NR1 exon-5 to control NMDAR modulation by pregnenolone sulfate and protons.

Authors:  Emmanuel Kostakis; Ming-Kuei Jang; Shelley J Russek; Terrell T Gibbs; David H Farb
Journal:  J Neurochem       Date:  2011-09-28       Impact factor: 5.372

Review 5.  Neurosteroids and GABAergic signaling in health and disease.

Authors:  Georgina MacKenzie; Jamie Maguire
Journal:  Biomol Concepts       Date:  2013-02

6.  Brain distribution and behavioral effects of progesterone and pregnenolone after intranasal or intravenous administration.

Authors:  Nicole Ducharme; William A Banks; John E Morley; Sandra M Robinson; Michael L Niehoff; Claudia Mattern; Susan A Farr
Journal:  Eur J Pharmacol       Date:  2010-06-08       Impact factor: 4.432

7.  The neuroactive steroid pregnenolone sulfate stimulates trafficking of functional N-methyl D-aspartate receptors to the cell surface via a noncanonical, G protein, and Ca2+-dependent mechanism.

Authors:  Emmanuel Kostakis; Conor Smith; Ming-Kuei Jang; Stella C Martin; Kyle G Richards; Shelley J Russek; Terrell T Gibbs; David H Farb
Journal:  Mol Pharmacol       Date:  2013-05-28       Impact factor: 4.436

Review 8.  Pregnenolone sulfate as a modulator of synaptic plasticity.

Authors:  Conor C Smith; Terrell T Gibbs; David H Farb
Journal:  Psychopharmacology (Berl)       Date:  2014-07-06       Impact factor: 4.530

9.  Downregulation of sulfotransferase expression and activity in diseased human livers.

Authors:  Emine B Yalcin; Vijay More; Karissa L Neira; Zhenqiang James Lu; Nathan J Cherrington; Angela L Slitt; Roberta S King
Journal:  Drug Metab Dispos       Date:  2013-06-17       Impact factor: 3.922

10.  A role for picomolar concentrations of pregnenolone sulfate in synaptic activity-dependent Ca2+ signaling and CREB activation.

Authors:  Conor C Smith; Stella C Martin; Kavitha Sugunan; Shelley J Russek; Terrell T Gibbs; David H Farb
Journal:  Mol Pharmacol       Date:  2014-07-23       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.